The NASDAQ Biotechnology Index contains securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.
What is the Biotechnology Index?
The Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering clinical trial stage of development.
What is a regulated biotech index?
Regulated Biotech Index lowers your risk of loss of deposited trading funds. Lowering your risk is one of the benefits of working with a properly regulated Biotech Index. Consumers are protected by Biotech Index regulation, critical to preventing inadequate services and potential financial harm.
